Validating the Target Functions and Synergistic Multi-Target, Multi-Pathway Action Mode of Compound Kushen Injection Using CRISPR/CAS
H. Shen, S. Nourmohammadi, Y. Zhou, Y. Harata-Lee, Z. Qu, W. Wang, A. J. Yool, D. L. Adelson
This study validates the multi-target, multi-pathway action of Compound Kushen Injection by knocking out key genes in cell lines and observing changes in CKI efficacy.
bioRxiv · May 3, 2024 · PreprintPharmacology & Toxicology